Anna Kazanchyan, Director at Foamix Pharmaceuticals Ltd. (FOMX), sold 7,049 shares at $3.27 ($23K) on 2019-08-26, disclosed to the SEC on 2019-08-28.
Open-market sale of $23k FOMX by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |